B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

LMNA

MOLECULAR TARGET

lamin A/C

UniProt: P02545NCBI Gene: 40002 compounds

LMNA (lamin A/C) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting LMNA

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1molibresib3.8144
2Histamine0.691

About LMNA as a Drug Target

LMNA (lamin A/C) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented LMNA interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

LMNA inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.